Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • C-reactive protein point-of-care testing

Title

Output Type

Speciality

Published

Title

C-reactive protein point-of-care testing

Output Type

Advice Statement

Speciality

Infectious disease, Respiratory system

Published

8 May 2018

Recommendation for NHSScotland

Using C-reactive protein (CRP) point-of-care testing as part of the holistic clinical assessment of adult patients attending primary care with symptoms of lower respiratory tract infection shows potential as a cost-effective way to target antibiotic prescribing. However, the size of the reduction in antibiotic prescribing and the likely impact on clinical practice is unknown. There is little published evidence on the use of the test in children or older people. Additional piloting, with monitoring and evaluation, should be undertaken by the organisations in Scotland with responsibility for diagnostic testing, prior to any widespread implementation of CRP testing.

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

What were we asked to look at?

We were asked to provide advice on clinical and cost-effectiveness of C-reactive protein point-of-care testing to guide antibiotic prescribing in patients presenting to primary care with symptoms of lower respiratory tract infection, based on the published literature. 

Why is this important?

Microbial resistance to antibiotics is a major public health issue. Improving the targeting of antibiotics to those patients who are most likely to benefit is one strategy for addressing this issue. Around 80% of medical antibiotic use is in primary care and, of that, 60% is for respiratory infections. Thus it is important to evaluate initiatives which have the potential to reduce unnecessary use of antibiotics for self-limiting respiratory infections.

Referred by

Scottish Antimicrobial Prescribing Group (SAPG) and The Scottish Health Protection Network Public Health Microbiology Group.

 

Download icon
Download Advice
pdf (364 KB)
Download icon
Download Plain Language Summary
pdf (336 KB)
Download icon
Download Evidence Note
pdf (743 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 3 August 2021

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?